Literature DB >> 16307961

Will microbicide trials yield unbiased estimates of microbicide efficacy?

James Trussell1, Rosalie Dominik.   

Abstract

OBJECTIVE: To evaluate the effect of adherence and condom use on apparent efficacy of microbicides.
DESIGN: Hypothetical trial designs and scenarios.
METHODS: Mathematical calculations of effectiveness.
RESULTS: In a randomized trial of a candidate microbicide and a placebo, nonuse of the microbicide will result in underestimation of microbicide efficacy, with the magnitude of this difference between effectiveness and efficacy increasing directly with the level of microbicide nonuse. Adding condoms to the trial will not change this expected result as long as use of condoms and microbicide is independent, and microbicide use is the same in the trials with and without condoms. However, if microbicide use is lower in the trial with condoms, then effectiveness will be lower than in the trial without condoms, with the magnitude of the difference between effectiveness and efficacy being even greater. Moreover, condom and microbicide use may not be independent. If participants tend to use condoms rather than nothing, the trial result will more closely approximate microbicide efficacy. If, however, participants substitute condom use for microbicide use, then the expected estimate of effectiveness will less closely approximate microbicide efficacy and could be closer to or further away from the expected estimate of effectiveness than in the trial without condoms. In another trial design, where there is either simultaneous use of microbicide and condoms or no use of either (guaranteed when condoms are packaged with either a microbicidal or a placebo gel), expected effectiveness will fall short of microbicide efficacy. If nonuse is the same in a trial without condoms and a trial with microbicidally lubricated condoms, then the trial with condoms will produce an estimate of effectiveness that less closely approximates microbicide efficacy than would the trial without condoms. If there is less nonuse in the trial with condoms, then the expected estimate of effectiveness will more closely approximate microbicide efficacy and could be closer to or further away from the expected estimate of effectiveness than in the trial without condoms.
CONCLUSIONS: Nonuse of a microbicide and use of condoms may seriously impair our ability to identify an effective microbicide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307961     DOI: 10.1016/j.contraception.2005.06.063

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  9 in total

1.  Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?

Authors:  Barbara S Mensch; Elizabeth R Brown; Karen Liu; Jeanne Marrazzo; Zvavahera Mike Chirenje; Kailazarid Gomez; Jeanna Piper; Karen Patterson; Ariane van der Straten
Journal:  AIDS Behav       Date:  2016-11

2.  An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.

Authors:  Sharon A Abbott; Barbara A Friedland; Avina Sarna; Lauren L Katzen; Ulrike Rawiel; Aylur K Srikrishnan; C S Shalini; Waimar Tun; Christine A Kelly; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2013-07

3.  Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial.

Authors:  Pamina M Gorbach; Barbara S Mensch; Marla Husnik; Astou Coly; Benoit Mâsse; Bonus Makanani; Chiwawa Nkhoma; Lameck Chinula; Tchangani Tembo; Stan Mierzwa; Kimberly Reynolds; Stacey Hurst; Anne Coletti; Andrew Forsyth
Journal:  AIDS Behav       Date:  2013-02

4.  Analyzing Direct Effects in Randomized Trials with Secondary Interventions: An Application to HIV Prevention Trials.

Authors:  Michael Rosenblum; Nicholas P Jewell; Mark van der Laan; Steve Shiboski; Ariane van der Straten; Nancy Padian
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-04       Impact factor: 2.483

5.  Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.

Authors:  Barbra A Richardson; Cliff Kelly; Gita Ramjee; Thomas Fleming; Bonus Makanani; Sarah Roberts; Petina Musara; Nkhafwire Mkandawire; Thomas Moench; Anne Coletti; Lydia Soto-Torres; Salim A Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

6.  Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.

Authors:  Barbara A Friedland; Marie Stoner; Michelle M Chau; Marlena Gehret Plagianos; Sumen Govender; Neetha Morar; Lydia Altini; Stephanie Skoler-Karpoff; Khatija Ahmed; Gita Ramjee; Constance Monedi; Robin Maguire; Pekka Lähteenmäki
Journal:  AIDS Behav       Date:  2016-11

7.  Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials.

Authors:  Lori Miller; Neetha Morar; Saidi Kapiga; Gita Ramjee; Richard Hayes
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

8.  Efficacy dilution in randomized placebo-controlled vaginal microbicide trials.

Authors:  Benoît R Mâsse; Marie-Claude Boily; Dobromir Dimitrov; Kamal Desai
Journal:  Emerg Themes Epidemiol       Date:  2009-10-09

9.  SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

Authors:  Leigh Peterson; Kavita Nanda; Baafuor Kofi Opoku; William Kwabena Ampofo; Margaret Owusu-Amoako; Andrew Yiadom Boakye; Wes Rountree; Amanda Troxler; Rosalie Dominik; Ronald Roddy; Laneta Dorflinger
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.